Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rFVIIa Bolus vs Continuous Infusion in Hemophilia Surgery
NCT01561391Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 1998
- Primary completion
- May 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of coagulation factor VIIa in hemophilia A, hemophilia B (HB), sponsored by Novo Nordisk. Started Apr 1998; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT01561391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01561391.